The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Brain malignancies: Glioblastoma and brain metastases
Open accessAbstract
Brain, the major organ of the central nervous system controls and processes most of body activities. Therefore, the most aggressive brain tumor - glioblastoma and metastases from other organs to the brain are lethal leaving the patients with very short time of survival. The brain tissue landscape is very different from any other tissues and the specific microenvironment, comprising stem cells niches and blood-brain barrier, significantly influences the low rate of glioblastoma metastasis out of the brain, but better accommodates brain-invading cancer. In contrast to low frequency (0.5%) of all glioblastoma metastases, 10%-45% of other primary cancers do metastasize to the brain. This review addresses general cellular and molecular pathways that are to some extent similar in both types of metastases, involving circulating tumor cells (CTCs) with cancer stem cells (CSCs) characteristics, and metastatic niches. The invasion is a dynamic process involving reversible epithelial-to-mesenchymal (EMT) cell process, creating a transient gradient state that is inter-connected with epigenetic plasticity of the metastasizing (m)CSCs. These cells can switch between stationary, low proliferating/dormant state to a migratory, mesenchymal-like state. Settling in their respective niches as dormant CSCs in the secondary organ is a common feature in all types of metastases. In glioblastoma metastasis, the malignant mGSC cells express markers of mesenchymal GSC subtype (MES-GSC), such as CD44 and YK-40 and their major obstacle seems to be propagating in the in various organs' microenvironments, different from the niches that home GSCs in the primary glioblastoma. Focusing on one stromal component in the glioblastoma niches, the mesenchymal stem cells (MSCs), we report herein on their differential effects on glioblastoma cells, highly depending on their genetic subtype. On the other hand, in brain metastases, the major hindrance to metastatic progression of mCSCs seem to be crossing the blood-brain-barrier. Novel therapeutic approaches for brain metastases from various cancer types are advancing slowly, and the general trends involve targeting metastatic sub-clones and selective determinants of their niches. The update on the four most common brain metastases from lung, breast, melanoma and colorectal carcinoma is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381
First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer
Solomon, B. J., Mok, T., Kim, D.-W., Wu, Y.-L., Nakagawa, K., Mekhail, T., Felip, E., Cappuzzo, F., Paolini, J., Usari, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408440 · Cited by 3,190
Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109653 · Cited by 2,863
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377
Pàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
Gershenwald, J. E., Scolyer, R. A., Hess, K. R., Sondak, V. K., Long, G. V., Ross, M. I., Lazar, A. J., Faries, M. B., Kirkwood, J. M., McArthur, G. A., et al. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21409 · Cited by 2,283
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Swain, S. M., Baselga, J., Kim, S.-B., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Heeson, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413513 · Cited by 2,164
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
Pre-metastatic niches: organ-specific homes for metastases
Peinado, H., Zhang, H., Matei, I. R., Costa-Silva, B., Hoshino, A., Rodrigues, G., Psaila, B., Kaplan, R. N., Bromberg, J. F., Kang, Y., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.6 · Cited by 1,889
Metastasis: a question of life or death
Mehlen, P., & Puisieux, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1886 · Cited by 1,863
The Microenvironmental Landscape of Brain Tumors
Quail, D. F., & Joyce, J. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.009 · Cited by 1,862
Basement membranes: structure, assembly and role in tumour angiogenesis
Kalluri, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1094 · Cited by 1,748
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
Yang, J. C.-H., Wu, Y.-L., Schuler, M., Sebastian, M., Popat, S., Yamamoto, N., Zhou, C., Hu, C.-P., O'Byrne, K., Feng, J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71173-8 · Cited by 1,574
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Plaks, V., Kong, N., & Werb, Z. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.02.015 · Cited by 1,557
Cancer stem cells in glioblastoma
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. L., & Rich, J. N. (2015) · Genes & Development · doi:10.1101/gad.261982.115 · Cited by 1,520
Ceritinib in ALK -Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Kim, D.-W., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J., Sharma, S., De Pas, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311107 · Cited by 1,495
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
Van Meir, E. G., Hadjipanayis, C. G., Norden, A. D., Shu, H. K., Wen, P. Y., & Olson, J. J. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20069 · Cited by 1,372
Steeg, P. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.25 · Cited by 1,363
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
Extracellular matrix: A dynamic microenvironment for stem cell niche
Gattazzo, F., Urciuolo, A., & Bonaldo, P. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.01.010 · Cited by 1,294
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., & Beier, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4180 · Cited by 1,153
Soria, J.-C., Tan, D. S. W., Chiari, R., Wu, Y.-L., Paz-Ares, L., Wolf, J., Geater, S. L., Orlov, S., Cortinovis, D., Yu, C.-J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30123-x · Cited by 1,151
Real-time imaging reveals the single steps of brain metastasis formation.
Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E. F., Goldbrunner, R., Herms, J., & Winkler, F. (2010) · Nature Medicine · doi:10.1038/nm.2072 · Cited by 1,138
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Bhat, K. P. L., Balasubramaniyan, V., Vaillant, B., Ezhilarasan, R., Hummelink, K., Hollingsworth, F., Wani, K., Heathcock, L., James, J. D., Goodman, L. D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.001 · Cited by 1,102
Brastianos, P. K., Carter, S. L., Santagata, S., Cahill, D. P., Taylor-Weiner, A., Jones, R. T., Van Allen, E. M., Lawrence, M. S., Horowitz, P. M., Cibulskis, K., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0369 · Cited by 1,082
Achrol, A. S., Rennert, R. C., Anders, C., Soffietti, R., Ahluwalia, M. S., Nayak, L., Peters, S., Arvold, N. D., Harsh, G. R., Steeg, P. S., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0055-y · Cited by 1,034
Ascierto, P. A., McArthur, G. A., Dréno, B., Atkinson, V., Liszkay, G., Di Giacomo, A. M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30122-x · Cited by 1,022
Vescovi, A. L., Galli, R., & Reynolds, B. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1889 · Cited by 990
Hida, T., Nokihara, H., Kondo, M., Kim, Y. H., Azuma, K., Seto, T., Takiguchi, Y., Nishio, M., Yoshioka, H., Imamura, F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30565-2 · Cited by 911
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
Valiente, M., Obenauf, A. C., Jin, X., Chen, Q., Zhang, X. H.-F., Lee, D. J., Chaft, J. E., Kris, M. G., Huse, J. T., Brogi, E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.040 · Cited by 877
A neurocentric perspective on glioma invasion
Cuddapah, V. A., Robel, S., Watkins, S., & Sontheimer, H. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3765 · Cited by 831
Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells
Kollet, O., Dar, A., Shivtiel, S., Kalinkovich, A., Lapid, K., Sztainberg, Y., Tesio, M., Samstein, R. M., Goichberg, P., Spiegel, A., et al. (2006) · Nature Medicine · doi:10.1038/nm1417 · Cited by 775
Microenvironmental regulation of therapeutic response in cancer
Klemm, F., & Joyce, J. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.006 · Cited by 771
Chapman, P. B., Einhorn, L. H., Meyers, M. L., Saxman, S., Destro, A. N., Panageas, K. S., Begg, C. B., Agarwala, S. S., Schuchter, L. M., Ernstoff, M. S., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2745 · Cited by 764
Early dissemination seeds metastasis in breast cancer
Hosseini, H., Obradović, M. M. S., Hoffmann, M., Harper, K. L., Sosa, M. S., Werner-Klein, M., Nanduri, L. K., Werno, C., Ehrl, C., Maneck, M., et al. (2016) · Nature · doi:10.1038/nature20785 · Cited by 740
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 721
The brain tumor microenvironment
Charles, N. A., Holland, E. C., Gilbertson, R., Glass, R., & Kettenmann, H. (2012) · Glia · doi:10.1002/glia.21264 · Cited by 712
Defining the Hallmarks of Metastasis
Welch, D. R., & Hurst, D. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0458 · Cited by 700
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
Olson, O. C., & Joyce, J. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4027 · Cited by 699
Sperduto, P. W., Yang, T. J., Beal, K., Pan, H., Brown, P. D., Bangdiwala, A., Shanley, R., Yeh, N., Gaspar, L. E., Braunstein, S., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3834 · Cited by 659
Shaw, A. T., Felip, E., Bauer, T. M., Besse, B., Navarro, A., Postel-Vinay, S., Gainor, J. F., Johnson, M., Dietrich, J., James, L. P., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30680-0 · Cited by 659
The cerebrospinal fluid provides a proliferative niche for neural progenitor cells
Lehtinen, M. K., Zappaterra, M. W., Chen, X., Yang, Y. J., Hill, A. D., Lun, M., Maynard, T., Gonzalez, D., Kim, S., Ye, P., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.023 · Cited by 648
Diffuse glioma growth: a guerilla war
Claes, A., Idema, A. J., & Wesseling, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0293-7 · Cited by 636
Dummer, R., Ascierto, P. A., Gogas, H. J., Arance, A., Mandala, M., Liszkay, G., Garbe, C., Schadendorf, D., Krajsova, I., Gutzmer, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30497-2 · Cited by 588
Kim, D.-W., Tiseo, M., Ahn, M.-J., Reckamp, K. L., Hansen, K. H., Kim, S.-W., Huber, R. M., West, H. L., Groen, H. J. M., Hochmair, M. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.5904 · Cited by 581
Multidimensional communication in the microenvirons of glioblastoma
Broekman, M. L., Maas, S. L. N., Abels, E. R., Mempel, T. R., Krichevsky, A. M., & Breakefield, X. O. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0025-8 · Cited by 579
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
Wang, J., Sakariassen, P. Ø., Tsinkalovsky, O., Immervoll, H., Bøe, S. O., Svendsen, A., Prestegarden, L., Røsland, G., Thorsen, F., Stuhr, L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23130 · Cited by 567
Proteolytic networks in cancer
Mason, S. D., & Joyce, J. A. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.12.002 · Cited by 552
Mesenchymal stem cells: key players in cancer progression
Ridge, S. M., Sullivan, F. J., & Glynn, S. A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0597-8 · Cited by 526
Glioblastoma: defining tumor niches
Hambardzumyan, D., & Bergers, G. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.009 · Cited by 522
Oncogenic PI3K and its role in cancer
Samuels, Y., & Ericson, K. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000198021.99347.b9 · Cited by 521
Cancer stem cell niche: the place to be
Borovski, T., De Sousa E Melo, F., Vermeulen, L., & Medema, J. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3220 · Cited by 518
André, F., O'Regan, R., Ozguroglu, M., Toi, M., Xu, B., Jerusalem, G., Masuda, N., Wilks, S., Arena, F., Isaacs, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70138-x · Cited by 493
Quantitative evidence for early metastatic seeding in colorectal cancer
Hu, Z., Ding, J., Ma, Z., Sun, R., Seoane, J. A., Scott Shaffer, J., Suarez, C. J., Berghoff, A. S., Cremolini, C., Falcone, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0423-x · Cited by 490
Ludwig, K., & Kornblum, H. I. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2379-y · Cited by 418
Miroshnikova, Y. A., Mouw, J. K., Barnes, J. M., Pickup, M. W., Lakins, J. N., Kim, Y., Lobo, K., Persson, A. I., Reis, G. F., McKnight, T. R., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3429 · Cited by 383
Unravelling biology and shifting paradigms in cancer with single-cell sequencing
Baslan, T., & Hicks, J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.58 · Cited by 381
Brain metastases as preventive and therapeutic targets
Steeg, P. S., Camphausen, K. A., & Smith, Q. R. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3053 · Cited by 363
The landscape of the mesenchymal signature in brain tumours
Behnan, J., Finocchiaro, G., & Hanna, G. (2019) · Brain · doi:10.1093/brain/awz044 · Cited by 350
Hematogenous dissemination of glioblastoma multiforme
Müller, C., Holtschmidt, J., Auer, M., Heitzer, E., Lamszus, K., Schulte, A., Matschke, J., Langer-Freitag, S., Gasch, C., Stoupiec, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009095 · Cited by 328
Structural Development in Gliomas
Scherer, H.-J. (1938) · American Journal of Cancer · doi:10.1158/ajc.1938.333 · Cited by 314
Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
Campos, B., Wan, F., Farhadi, M., Ernst, A., Zeppernick, F., Tagscherer, K. E., Ahmadi, R., Lohr, J., Dictus, C., Gdynia, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1800 · Cited by 313
Tissue-specific tumorigenesis: context matters
Schneider, G., Schmidt-Supprian, M., Rad, R., & Saur, D. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.5 · Cited by 311
Gliomas and the vascular fragility of the blood brain barrier
Dubois, L. G., Campanati, L., Righy, C., D’Andrea-Meira, I., Spohr, T. C. L. D. S. E., Porto-Carreiro, I., Pereira, C. M., Balça-Silva, J., Kahn, S. A., DosSantos, M. F., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00418 · Cited by 303
Papaccio, F., Paino, F., Regad, T., Papaccio, G., Desiderio, V., & Tirino, V. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0138 · Cited by 292
Epithelial-mesenchymal transition in glioblastoma progression
IWADATE, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4113 · Cited by 288
Wang, X., Prager, B. C., Wu, Q., Kim, L. J. Y., Gimple, R. C., Shi, Y., Yang, K., Morton, A. R., Zhou, W., Zhu, Z., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.03.011 · Cited by 285
The cancer stem cell niche—there goes the neighborhood?
Cabarcas, S. M., Mathews, L. A., & Farrar, W. L. (2011) · International Journal of Cancer · doi:10.1002/ijc.26312 · Cited by 265
Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
Marchesi, F., Piemonti, L., Mantovani, A., & Allavena, P. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.001 · Cited by 260
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
Sullivan, J. P., Nahed, B. V., Madden, M. W., Oliveira, S. M., Springer, S., Bhere, D., Chi, A. S., Wakimoto, H., Rothenberg, S. M., Sequist, L. V., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0471 · Cited by 255
del Pozo Martin, Y., Park, D., Ramachandran, A., Ombrato, L., Calvo, F., Chakravarty, P., Spencer-Dene, B., Derzsi, S., Hill, C. S., Sahai, E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.025 · Cited by 248
Otvos, B., Silver, D. J., Mulkearns-Hubert, E. E., Alvarado, A. G., Turaga, S. M., Sorensen, M. D., Rayman, P., Flavahan, W. A., Hale, J. S., Stoltz, K., et al. (2016) · Stem Cells · doi:10.1002/stem.2393 · Cited by 245
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype
Almog, N., Ma, L., Raychowdhury, R., Schwager, C., Erber, R., Short, S., Hlatky, L., Vajkoczy, P., Huber, P. E., Folkman, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2590 · Cited by 240
Feng, S., Cen, J., Huang, Y., Shen, H., Yao, L., Wang, Y., & Chen, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020599 · Cited by 236
Berghoff, A. S., Schur, S., Füreder, L. M., Gatterbauer, B., Dieckmann, K., Widhalm, G., Hainfellner, J., Zielinski, C. C., Birner, P., Bartsch, R., et al. (2016) · ESMO Open · doi:10.1136/esmoopen-2015-000024 · Cited by 236
Hossain, A., Gumin, J., Gao, F., Figueroa, J., Shinojima, N., Takezaki, T., Priebe, W., Villarreal, D., Kang, S.-G., Joyce, C., et al. (2015) · Stem Cells · doi:10.1002/stem.2053 · Cited by 224
The natural history of extracranial metastasis from glioblastoma multiforme
Lun, M., Lok, E., Gautam, S., Wu, E., & Wong, E. T. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0575-8 · Cited by 223
Long, G. V., Eroglu, Z., Infante, J., Patel, S., Daud, A., Johnson, D. B., Gonzalez, R., Kefford, R., Hamid, O., Schuchter, L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.1025 · Cited by 221
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation
Minata, M., Audia, A., Shi, J., Lu, S., Bernstock, J., Pavlyukov, M. S., Das, A., Kim, S.-H., Shin, Y. J., Lee, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.076 · Cited by 220
Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes?
Li, Y., & Laterra, J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3070 · Cited by 219
Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma
Ma, Q., Long, W., Xing, C., Chu, J., Luo, M., Wang, H. Y., Liu, Q., & Wang, R.-F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02924 · Cited by 219
Gibson, W. J., Hoivik, E. A., Halle, M. K., Taylor-Weiner, A., Cherniack, A. D., Berg, A., Holst, F., Zack, T. I., Werner, H. M. J., Staby, K. M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3602 · Cited by 206
Pericellular proteolysis in cancer
Sevenich, L., & Joyce, J. A. (2014) · Genes & Development · doi:10.1101/gad.250647.114 · Cited by 193
Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination
Sanborn, J. Z., Chung, J., Purdom, E., Wang, N. J., Kakavand, H., Wilmott, J. S., Butler, T., Thompson, J. F., Mann, G. J., Haydu, L. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508074112 · Cited by 192
Xing, F., Kobayashi, A., Okuda, H., Watabe, M., Pai, S. K., Pandey, P. R., Hirota, S., Wilber, A., Mo, Y., Moore, B. E., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201623 · Cited by 190
Breast cancer stem cells: Features, key drivers and treatment options
Dittmer, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.007 · Cited by 188
Yaeger, R., Cowell, E., Chou, J. F., Gewirtz, A. N., Borsu, L., Vakiani, E., Solit, D. B., Rosen, N., Capanu, M., Ladanyi, M., et al. (2015) · Cancer · doi:10.1002/cncr.29196 · Cited by 187
Alvarado, A. G., Thiagarajan, P. S., Mulkearns-Hubert, E. E., Silver, D. J., Hale, J. S., Alban, T. J., Turaga, S. M., Jarrar, A., Reizes, O., Longworth, M. S., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.12.001 · Cited by 187
Halliday, J., Helmy, K., Pattwell, S. S., Pitter, K. L., LaPlant, Q., Ozawa, T., & Holland, E. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321014111 · Cited by 185
Freedman, R. A., Gelman, R. S., Wefel, J. S., Melisko, M. E., Hess, K. R., Connolly, R. M., Van Poznak, C. H., Niravath, P. A., Puhalla, S. L., Ibrahim, N., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0343 · Cited by 171
Brain metastasis: Unique challenges and open opportunities
Lowery, F. J., & Yu, D. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.12.001 · Cited by 170
Breast cancer brain metastases: the last frontier
Leone, J. P., & Leone, B. A. (2015) · Experimental Hematology & Oncology · doi:10.1186/s40164-015-0028-8 · Cited by 168
Genetic insights into the morass of metastatic heterogeneity
Hunter, K. W., Amin, R., Deasy, S., Ha, N.-H., & Wakefield, L. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.126 · Cited by 163
The Difficulty of Targeting Cancer Stem Cell Niches
LaBarge, M. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2933 · Cited by 162
Mechanisms and Therapy for Cancer Metastasis to the Brain
Franchino, F., Rudà, R., & Soffietti, R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00161 · Cited by 161
Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling
Skvortsova, I., Debbage, P. L., Kumar, V., & Skvortsov, S. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.009 · Cited by 155
Do all roads lead to Rome? Routes to metastasis development
Sleeman, J. P., Nazarenko, I. A., & Thiele, W. (2011) · International Journal of Cancer · doi:10.1002/ijc.26027 · Cited by 153
Niessner, H., Forschner, A., Klumpp, B. D., Honegger, J. B., Witte, M. B., Bornemann, A., Dummer, R., ADAM, A., Bauer, J. M., Tabatabai, G., et al. (2012) · Cancer Medicine · doi:10.1002/cam4.50 · Cited by 143
Metastasis Suppressor Genes: Basic Biology and Potential Clinical Use
Steeg, P. S., Ouatas, T., Halverson, D. O., Palmieri, D., & Salerno, M. (2003) · Clinical Breast Cancer · doi:10.3816/cbc.2003.n.012 · Cited by 139
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases
Dudnik, E., Yust‐Katz, S., Nechushtan, H., Goldstein, D. A., Zer, A., Flex, D., Siegal, T., & Peled, N. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.05.031 · Cited by 134
EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
Weidenfeld, K., & Barkan, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00381 · Cited by 131
Zhao, Y., Dong, Q., Li, J., Zhang, K., Qin, J., Zhao, J., Sun, Q., Wang, Z., Wartmann, T., Jauch, K. W., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.002 · Cited by 129
Saunus, J. M., Quinn, M. C. J., Patch, A., Pearson, J. V., Bailey, P. J., Nones, K., Reed, A. E. M., Miller, D. K., Wilson, P. J., Al‐Ejeh, F., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4583 · Cited by 125
Cortés, J., Dieras, V. C., Ro, J., Barrière, J., Bachelot, T., Hurvitz, S. A., Rhun, É. L., Espié, M., Kim, S., Schneeweiß, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00373-3 · Cited by 125
Activity of T-DM1 in Her2-positive breast cancer brain metastases
Bartsch, R., Berghoff, A. S., Vogl, U. M., Rudas, M., Bergen, E. S., Dubsky, P. C., Dieckmann, K. U., Pinker, K., Bagó-Horváth, Z., Galid, A., et al. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9740-3 · Cited by 119
Petrelli, F., Ghidini, M., Lonati, V., Tomasello, G., Borgonovo, K., Ghilardi, M., Cabiddu, M., & Barni, S. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.024 · Cited by 115
Breast cancer brain metastasis: molecular mechanisms and directions for treatment
Pedrosa, R. M. S. M., Mustafa, D. A. M., Soffietti, R., & Kros, J. M. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy044 · Cited by 110
Trastuzumab Emtansine: A Novel Antibody–Drug Conjugate for HER2-Positive Breast Cancer
Krop, I. E., & Winer, E. P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0541 · Cited by 105
AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases
Yang, Z., Guo, Q., Wang, Y., Chen, K., Zhang, L., Cheng, Z., Xu, Y., Yin, X., Bai, Y., Rabbie, S. C., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0976 · Cited by 103
Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression
Verbovšek, U., Noorden, C. J. F. V., & Lah, T. T. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.010 · Cited by 99
Self-citationTargeted Therapies for Brain Metastases from Breast Cancer
Venur, V. A., & Leone, J. P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091543 · Cited by 96
Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases
Sun, J., Wang, C., Zhang, Y., Xu, L., Fang, W. J., Zhu, Y., Zheng, Y., Chen, X., Xie, X., Hu, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10987-3 · Cited by 96
Tumor Plasticity Allows Vasculogenic Mimicry, a Novel Form of Angiogenic Switch
Bissell, M. J. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65164-4 · Cited by 94
Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas
Zhang, Q., Xiang, W., Yi, D., Xue, B., Wen, W., Abdelmaksoud, A., Xiong, N., Jiang, X., Zhao, H., & Fu, P. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0977-z · Cited by 93
Brain matrix: structure, turnover and necessity
Rauch, U. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350656 · Cited by 92
Marquardt, S., Solanki, M., Spitschak, A., Vera, J., & Pützer, B. M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.06.006 · Cited by 92
Evolutionary dynamics of residual disease in human glioblastoma
Spiteri, I., Caravagna, G., Cresswell, G. D., Vatsiou, A. I., Nichol, D., Acar, A., Ermini, L., Chkhaidze, K., Werner, B., Mair, R. J., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy506 · Cited by 90
Winkler, F. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1357-0 · Cited by 88
Antiprotease therapy in cancer: hot or not?
Lah, T. T., Alonso, M. B. D., & Noorden, C. J. F. V. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.3.257 · Cited by 87
Self-citationJiang, T., Min, W., Li, Y., Yue, Z., Wu, C., & Zhou, C. (2016) · Cancer Medicine · doi:10.1002/cam4.673 · Cited by 87
Shi, Y., Zhou, W., Cheng, L., Chen, C., Huang, Z., Fang, X., Wu, Q., He, Z., Xu, S., Lathia, J. D., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.110 · Cited by 86
Lost in disruption: Role of proteases in glioma invasion and progression
Mentlein, R., Hattermann, K., & Held-Feindt, J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.12.001 · Cited by 85
Cancer cell lines release glutamate into the extracellular environment
Seidlitz, E. P., Sharma, M. K., Saikali, Z., Ghert, M. A., & Singh, G. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9277-4 · Cited by 85
Hira, V. V. V., Ploegmakers, K. J., Grevers, F., Verbovšek, U., Silvestre-Roig, C., Aronica, E., Tigchelaar, W., Turnšek, T. L., Molenaar, R. J., & Noorden, C. J. F. V. (2015) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415581689 · Cited by 85
Pavon, L. F., Sibov, T. T., de Souza, A. V., da Cruz, E. F., Malheiros, S. M. F., Cabral, F. R., de Souza, J. G., Boufleur, P., de Oliveira, D. M., de Toledo, S. R. C., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1049-0 · Cited by 84
Podergajs, N., Motaln, H., Rajčević, U., Verbovšek, U., Koršič, M., Obad, N., Espedal, H., Vittori, M., Herold-Mende, C., Miletic, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.5477 · Cited by 81
Shahar, T., Rozovski, U., Hess, K. R., Hossain, A., Gumin, J., Gao, F., Fuller, G. N., Goodman, L. D., Sulman, E. P., & Lang, F. F. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now239 · Cited by 81
Kozłowska, A. K., Topchyan, P., Kaur, K., Tseng, H.-C., Teruel, A., Hiraga, T., & Jewett, A. (2017) · Journal of Cancer · doi:10.7150/jca.15989 · Cited by 80
Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines
Breznik, B., Motaln, H., Vittori, M., Rotter, A., & Turnšek, T. L. (2017) · Oncotarget · doi:10.18632/oncotarget.16041 · Cited by 75
Self-citationGril, B., Palmieri, D., Qian, Y., Anwar, T., Liewehr, D. J., Steinberg, S. M., Andreu, Z., Masana, D., Fernández, P., Steeg, P. S., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.043 · Cited by 74
Motaln, H., Koren, A., Gruden, K., Ramšak, Ž., Schichor, C., & Lah, T. T. (2015) · Oncotarget · doi:10.18632/oncotarget.5701 · Cited by 73
Self-citationKološa, K., Motaln, H., Herold‐Mende, C. C., Koršič, M., & Lah, T. T. (2015) · Cell Transplantation · doi:10.3727/096368915x687787 · Cited by 65
Self-citationDifferential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency
Behnan, J., Stangeland, B., Hosainey, S. A. M., Joel, M., Olsen, T. K., Micci, F., Glover, J. C., Isakson, P., & Brinchmann, J. E. (2016) · Oncogene · doi:10.1038/onc.2016.230 · Cited by 65
Ionizing radiation augments glioma tropism of mesenchymal stem cells
Thomas, J. G., Kerrigan, B. C. P., Hossain, A., Gumin, J., Shinojima, N., Nwajei, F., Ezhilarasan, R., Love, P. N., Sulman, E. P., & Lang, F. F. (2017) · Journal of neurosurgery · doi:10.3171/2016.9.jns16278 · Cited by 63
Anghileri, E., Castiglione, M., Raffaele, N., Boffano, C., Nazzi, V., Acerbi, F., Finocchiaro, G., & Eoli, M. (2015) · Neurosurgical Review · doi:10.1007/s10143-015-0656-9 · Cited by 60
Mesenchymal stem cells and glioma cells form a structural as well as a functional syncytium in vitro
Schichor, C., Albrecht, V. S., Korte, B. G., Büchner, A., Riesenberg, R., Mysliwietz, J., Paron, I., Motaln, H., Turnšek, T. L., Jürchott, K., et al. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.033 · Cited by 59
Motaln, H., Gruden, K., Hren, M., Schichor, C., Primon, M., Rotter, A., & Lah, T. T. (2012) · Cell Transplantation · doi:10.3727/096368912x640547 · Cited by 58
Self-citationGlioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar
Hira, V. V. V., Aderetti, D. A., & Noorden, C. J. F. V. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417752676 · Cited by 58
Targeted Therapy in Brain Metastases: Ready for Primetime?
Venur, V. A., & Ahluwalia, M. S. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100006 · Cited by 57
Biology of brain metastases and novel targeted therapies: Time to translate the research
Fokas, E., Steinbach, J., & Rödel, C. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.005 · Cited by 56
Expression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma
Verbovšek, U., Motaln, H., Rotter, A., Atai, N. A., Gruden, K., Noorden, C. J. F. V., & Lah, T. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111819 · Cited by 54
Self-citationDissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models
Teng, J., da Hora, C. C., Kantar, R. S., Nakano, I., Wakimoto, H., Batchelor, T. T., Chiocca, E. A., Badr, C. E., & Tannous, B. A. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now253 · Cited by 53
Pericyte-Like Location of GFP-Tagged Melanoma Cells
Lugassy, C., Kleinman, H. K., Engbring, J. A., Welch, D. R., Harms, J. F., Rufner, R., Ghanem, G., Patierno, S. R., & Barnhill, R. L. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63207-5 · Cited by 50
Proteases and cytokines as mediators of interactions between cancer and stromal cells in tumours
Breznik, B., Motaln, H., & Turnšek, T. L. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0283 · Cited by 50
Self-citationTan, C., Cho, B. C., & Soo, R. A. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.02.012 · Cited by 45
Oliveira, M. N., Pillat, M. M., Motaln, H., Ulrich, H., & Lah, T. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-19359-1 · Cited by 43
Self-citationHira, V. V. V., Breznik, B., Vittori, M., de Jong, A. L., Mlakar, J., Oostra, R., Khurshed, M., Molenaar, R. J., Lah, T. T., & Noorden, C. J. F. V. (2019) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155419878416 · Cited by 41
Self-citationLow incidence of melanoma brain metastasis in the hippocampus
Hong, A., Suo, C., Valenzuela, M., Haydu, L. E., Jacobsen, K. D., Reisse, C. H., & Fogarty, G. B. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.01.012 · Cited by 40
Mu, Y., Hao, X., Yang, K., Ma, D., Wang, S., Xu, Z., Li, J., & Xing, P. (2019) · Targeted Oncology · doi:10.1007/s11523-019-00644-6 · Cited by 40
Brinker, A. E., Vivian, C. J., Koestler, D. C., Tsue, T. T., Jensen, R. A., & Welch, D. R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2194 · Cited by 38
Wu, S., Rao, M.-Y., Zhou, J., Lin, Q., Wang, Z., Chen, Y., & He, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.5828 · Cited by 33
Systemic dissemination of glioblastoma: literature review
Carvalho, J. A. D. V., Barbosa, C. C., Feher, O., Maldaun, M. V. C., de Camargo, V. P., de Moraes, F. Y., & Marta, G. N. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.3.460 · Cited by 32
Phage display discovery of novel molecular targets in glioblastoma-initiating cells
Liu, J. K., Lubelski, D., Schonberg, D. L., Wu, Q., Hale, J. S., Flavahan, W. A., Mulkearns-Hubert, E. E., Man, J., Hjelmeland, A. B., Yu, J. J., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.65 · Cited by 31
Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer
Churilla, T. M., & Weiss, S. E. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0695-9 · Cited by 26
Localization patterns of cathepsins K and X and their predictive value in glioblastoma
Breznik, B., Limbӓck-Stanic, C., Porčnik, A., Blejec, A., Krajnc, M. K., Boŝnjak, R., Kos, J., Noorden, C. J. F. V., & Lah, T. T. (2018) · Radiology and Oncology · doi:10.2478/raon-2018-0040 · Cited by 23
Self-citationPhilips, A., Henshaw, D. L., Lamburn, G., & O’Carroll, M. J. (2018) · Journal of Environmental and Public Health · doi:10.1155/2018/2170208 · Cited by 19
Brain metastases in colorectal cancer: prognostic factors and survival analysis
del Carpio, L. P., Manrique, A. C. V., Szafranska, J., Martín-Richard, M., Páez, D., Sebio, A., Espinosa, Í., Pons, P. G., Granyó, M. A., Joaquín, A. B., et al. (2018) · International Journal of Colorectal Disease · doi:10.1007/s00384-018-3107-6 · Cited by 19
Eze, C., Schmidt-Hegemann, N.-S., Roengvoraphoj, O., Dantes, M., & Manapov, F. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00088 · Cited by 10
Advances in the Systemic Treatment of Melanoma Brain Metastases
Friedlander, P. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85673 · Cited by 2
(2003) · PubMed
Metadata
- Authors
- Lah, T. T., Novak, M., & Breznik, B.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 60
- Pages
- 262-273
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2981521201
- Cited by
- 438
- References
- 180
- FWCI
- 17.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.